Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Jessica Cusato and Giovanni Di Perri.
Connection Strength

3.121
  1. Wastewater-based SARS-CoV-2 environmental monitoring for Piedmont, Italy. Environ Res. 2022 Jan; 203:111901.
    View in: PubMed
    Score: 0.241
  2. Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate are not transported by Concentrative Nucleoside Transporter 2. Diagn Microbiol Infect Dis. 2019 Jun; 94(2):202-204.
    View in: PubMed
    Score: 0.194
  3. Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study. J Antimicrob Chemother. 2018 06 01; 73(6):1659-1664.
    View in: PubMed
    Score: 0.193
  4. Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy. Pharmacogenomics. 2018 06 01; 19(8):701-707.
    View in: PubMed
    Score: 0.192
  5. Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients. Infect Genet Evol. 2018 06; 60:42-47.
    View in: PubMed
    Score: 0.189
  6. Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs. Cancer Chemother Pharmacol. 2018 03; 81(3):615-620.
    View in: PubMed
    Score: 0.188
  7. Influence of ABCB11 and HNF4a genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study. J Antimicrob Chemother. 2017 10 01; 72(10):2846-2849.
    View in: PubMed
    Score: 0.184
  8. Association of vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patients. Pharmacogenomics. 2017 May; 18(7):651-661.
    View in: PubMed
    Score: 0.179
  9. Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemia. Pharmacogenomics. 2017 May; 18(7):607-611.
    View in: PubMed
    Score: 0.179
  10. Preterm birth is not associated with asymptomatic/mild SARS-CoV-2 infection per se: Pre-pregnancy state is what matters. PLoS One. 2021; 16(8):e0254875.
    View in: PubMed
    Score: 0.060
  11. Real-life study on the pharmacokinetic of remdesivir in ICU patients admitted for severe COVID-19 pneumonia. Br J Clin Pharmacol. 2021 12; 87(12):4861-4867.
    View in: PubMed
    Score: 0.060
  12. Analytical Validation and Clinical Application of Rapid Serological Tests for SARS-CoV-2 Suitable for Large-Scale Screening. Diagnostics (Basel). 2021 May 12; 11(5).
    View in: PubMed
    Score: 0.059
  13. Prenatal Biochemical and Ultrasound Markers in COVID-19 Pregnant Patients: A Prospective Case-Control Study. Diagnostics (Basel). 2021 Feb 26; 11(3).
    View in: PubMed
    Score: 0.058
  14. Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery. J Reprod Immunol. 2021 04; 144:103285.
    View in: PubMed
    Score: 0.058
  15. Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients. Am J Obstet Gynecol. 2021 04; 224(4):391.e1-391.e7.
    View in: PubMed
    Score: 0.057
  16. The "scar" of a pandemic: Cumulative incidence of COVID-19 during the first trimester of pregnancy. J Med Virol. 2021 01; 93(1):537-540.
    View in: PubMed
    Score: 0.056
  17. Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease. J Antimicrob Chemother. 2020 07 01; 75(7):1772-1777.
    View in: PubMed
    Score: 0.056
  18. The Influence of Pharmacogenetic Variants in HIV/Tuberculosis Coinfected Patients in Uganda in the SOUTH Study. Clin Pharmacol Ther. 2019 08; 106(2):450-457.
    View in: PubMed
    Score: 0.051
  19. A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples. J Pharmacol Toxicol Methods. 2018 Nov - Dec; 94(Pt 2):29-35.
    View in: PubMed
    Score: 0.049
  20. Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. Br J Clin Pharmacol. 2018 11; 84(11):2535-2543.
    View in: PubMed
    Score: 0.049
  21. Daclatasvir Plasma Levels in a Cohort of Patients with Hepatitis C Virus Infection Taking Methadone: A Prospective Analysis. Eur Addict Res. 2018; 24(4):184-188.
    View in: PubMed
    Score: 0.049
  22. Pharmacokinetic Changes during Pregnancy According to Genetic Variants: a Prospective Study in HIV-Infected Patients Receiving Atazanavir-Ritonavir. Antimicrob Agents Chemother. 2018 07; 62(7).
    View in: PubMed
    Score: 0.048
  23. Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations. J Clin Pharmacol. 2018 12; 58(12):1550-1556.
    View in: PubMed
    Score: 0.048
  24. Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens. Arch Virol. 2018 Apr; 163(4):961-967.
    View in: PubMed
    Score: 0.047
  25. Correlation between entecavir penetration in peripheral blood mononuclear cells and HBV DNA decay during treatment of HBeAg-negative chronic hepatitis B. Antivir Ther. 2018; 23(4):373-377.
    View in: PubMed
    Score: 0.047
  26. Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection. Biomedicines. 2017 Nov 20; 5(4).
    View in: PubMed
    Score: 0.046
  27. Cannabinoids concentration variability in cannabis olive oil galenic preparations. J Pharm Pharmacol. 2018 Jan; 70(1):143-149.
    View in: PubMed
    Score: 0.046
  28. Reasons to wait or to treat naive patients affected by chronic hepatitis C with low fibrosis stage and genotypes 2 or 3. Eur J Public Health. 2017 10 01; 27(5):938-941.
    View in: PubMed
    Score: 0.046
  29. Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children. Clin Exp Pharmacol Physiol. 2017 Nov; 44(11):1083-1088.
    View in: PubMed
    Score: 0.046
  30. The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin-induced anaemia in chronic hepatitis C Egyptian patients. Clin Exp Pharmacol Physiol. 2017 Sep; 44(9):965-968.
    View in: PubMed
    Score: 0.046
  31. A simple high performance liquid chromatography-mass spectrometry method for Therapeutic Drug Monitoring of isavuconazole and four other antifungal drugs in human plasma samples. J Pharm Biomed Anal. 2017 Oct 25; 145:718-724.
    View in: PubMed
    Score: 0.045
  32. Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics. Pharmacogenomics. 2017 Jun; 18(9):865-880.
    View in: PubMed
    Score: 0.045
  33. Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis C. Infect Genet Evol. 2017 09; 53:195-198.
    View in: PubMed
    Score: 0.045
  34. UHPLC-MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples. J Pharm Biomed Anal. 2017 Aug 05; 142:279-285.
    View in: PubMed
    Score: 0.045
  35. Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study. Infect Genet Evol. 2017 07; 51:167-172.
    View in: PubMed
    Score: 0.044
  36. Role of simeprevir plasma concentrations in HCV treated patients with dermatological manifestations. Dig Liver Dis. 2017 Jun; 49(6):705-708.
    View in: PubMed
    Score: 0.044
  37. Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Oct 01; 936:42-7.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.